American Portfolios Advisors Biocryst Pharmaceuticals Inc Transaction History
American Portfolios Advisors
- $2.36 Trillion
- Q3 2022
A detailed history of American Portfolios Advisors transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, American Portfolios Advisors holds 1,700 shares of BCRX stock, worth $11,339. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,700Holding current value
$11,339% of portfolio
0.0%Shares
7 transactions
Others Institutions Holding BCRX
# of Institutions
258Shares Held
182MCall Options Held
839KPut Options Held
816K-
Black Rock Inc. New York, NY18.4MShares$123 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.7MShares$118 Million0.0% of portfolio
-
State Street Corp Boston, MA17.5MShares$117 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY13.1MShares$87 Million0.8% of portfolio
-
Baker Bros. Advisors LP New York, NY10.1MShares$67.5 Million0.65% of portfolio
About BIOCRYST PHARMACEUTICALS INC
- Ticker BCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,944,992
- Market Cap $1.24B
- Description
- BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...